Rivio bets on guaranteed hospital revenue, not another software; US$21M at 6 months old

AI-run revenue-cycle management for hospitals: audits medical bills, contests denials, and collects from health plans — with a guarantee that Rivio covers any shortfall.

That hospitals don't need another billing software — they need a partner who guarantees they collect 100% of what health plans owe, with Rivio taking the risk.

US$21M total: Series A (Monashees, Valor Capital, Endeavor) plus a Positive Ventures extension, Dec 2025–Feb 2026

Founded in mid-2025 after the pair saw hospitals leaving R$5.8 billion in billings uncollected in 2024 (per Anahp). Instead of another software license, they designed an end-to-end service that audits accounts, integrates health-plan rules, automates billing, and carries the financial risk itself.

Six months after founding, in December 2025, Rivio raised R$100M (about US$20M) from Monashees and Valor Capital Group with Endeavor at a R$500M valuation. In February 2026 it added a US$1M extension from impact fund Positive Ventures. The platform was already in implementation at more than 50 hospital units, with partners reporting roughly 5% revenue gains in the first month.

Still scaling: technology live in 50+ hospital units as of early 2026, backed by what Valor Econômico called one of the largest rounds ever in a Latin American healthcare company under a year old; the stated goal is to become the operating system for healthcare administration in LatAm.

Both founders had proven they could build and exit large businesses: Sales sold Isaac to Arco for US$150M; Frison built Serasa Consumidor, the world's largest credit marketplace with 90M+ users.

The performance guarantee removes the buyer's main objection — software that doesn't pay for itself — because the vendor now shares the financial outcome.

The pain is concentrated and quantified: R$5.8 billion withheld from Brazilian hospitals in 2024 alone (Anahp), which makes the value proposition measurable before the first sale.

Backing from Monashees, Valor Capital, Endeavor and Positive Ventures signals that the risk-taking model, not just the AI, is what investors were underwriting.

Sell the outcome, not the tool: by guaranteeing reimbursement and taking the downside, Rivio changed the pitch from 'another system to buy' to 'who carries the risk'.

As of early February 2026, Rivio had announced US$21M in total funding (Monashees and Valor Capital Group leading the Series A with Endeavor, plus a US$1M Positive Ventures extension) and said its platform was in implementation at more than 50 hospital units across Brazil, including some of the largest healthcare brands in Latin America, with partner hospitals reporting around 5% revenue growth in the first month. The company's stated goal is to become the main operating system for healthcare administration in Latin America, starting with the revenue cycle.